Venture capital deals

October 15, 2013, 7:06 PM UTC
Fortune

Immatics Biotechnologies, a German developer of multi-peptide cancer vaccines, has raised €34 million in Series D funding. Return backers include Dievini Hopp Biotech, Wellington Partners, MIG-advised funds and AT Impf GmbH. www.immatics.com

Logi Analytics
, a McLean, Va.-based provider of embedded analytics solutions, has raised $27.5 million in growth equity funding. LLR Partners led the round, and was joined by return backer Updata Partners. www.logianalytics.com

Druva, a Sunnyvale, Calif.-based provider of data protection and governance solutions for enterprise devices, has raised $25 million in Series C funding. Tenaya Capital was joined by return backers Sequoia Capital and Nexus Venture Partners. The company previously raised $17 million.www.druva.com

SundaySky
, an Israel-based provider of video marketing solutions for online brands, has raised $20 million in Series C funding. Comcast Ventures led the round, and was joined by Liberty Global Ventures, Vintage Investment Partners and return backers Carmel Ventures, Globespan Capital Partners and Norwest Venture Partners. www.sundaysky.com

1366 Technologies
, a Bedford, Mass.-based silicon wafer manufacturer, has raised $15 million in Series C funding led by Tokuyama Corp. www.1366tech.com

Thinking Phone Networks
, a Cambridge, Mass.-based provider of unified communications as a service, has raised $10 million in new VC funding from return backers Bessemer Venture Partners andAdvanced Technology Ventureswww.thinkingphones.com

7signal
, an Akron, Ohio-based provider of wireless performance solutions, has raised $4 million in Series B funding. Allos Ventures and Mutual Capital Partners Funds co-led the round, and were joined by return backers like North Coast Angel Fund. www.7signal.com

SkyGiraffe
, an Israeli developer of an enterprise mobile platform for data-sharing, has raised an undisclosed amount of strategic funding from Microsoft Ventures. www.skygiraffe.com

Cisiv Ltd., a UK-based provider of SaaS solutions for data capture and management in long-term drug studies, has raised an undisclosed amount of VC funding from Albion Ventures. www.cisiv.com

Sign up for Dan Primack’s daily email newsletter on deals and deal-makers: GetTermSheet.com